Where Technology meets Opportunity in Science and Engineering
Home»Latest 30days News on Medical, Biotech/Pharma - weSRCH
Click category or weSRCH domain below to read news from each weSRCH domain
High Tech:-Business, Consumer, Displays, IT, Mobile, Photo, Semiconductors
Medicine:-Biology, Biotech/Pharma, Equipment, Imaging, Implants, Practice Mngmnt, Therapy, Veterinary
Green Tech:-Battery & Fuel, Biomass, Environmental, Fossil/Nuclear, Lighting, Solar, Trans, Wind/Water/Geo
Business:-Companies, Entrepreneurial, IP/Law, Leadership & Strategy, Management, Sales & Marketing, Social Innovation

Latest News, Top News, Breaking News

    Total record(s) 1136 , Page No. 1 , Max 20 Records Per Page -
    Page Nos. 1 2 3 4 5 6 7 8 9 10 .... Next >>
    EMA committee recommends AstraZeneca's ovarian cancer drug Lynparza - Pharmaceutical Business Review
      ... Morrison said the company is happy that the CHMP has recommended Lynparza as a first-in-class treatment option for women with BRCA-mutated ovarian cancer and they look forward to the ....more | Save |  Share  Email 24th Oct 2014 
    Regeneron Pharmaceuticals (REGN) Reaches New Lifetime High Today - TheStreet.com
      Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link. Trade-Ideas LLC ide ....more | Save |  Share  Email 24th Oct 2014 
    Superbug-driven surge in polymyxin demand prompts EMA to reassess safety - In-PharmaTechnologist.com
      BASF Pharma solutions for Orally Disintegrating Tablets BASF SE. BA Enhancement Series: Technology Selection Bend Research. Novel solutions for pediatrics and patients with swallowing difficulties. Caps ....more | Save |  Share  Email 24th Oct 2014 
    Vertex Pharmaceuticals' EPS Estimates Improved In Past Month - Forbes
      In the month leading up to the Vertex Pharmaceuticals' third quarter earnings announcement slated for Tuesday, October 28, 2014, expectations have risen for the upcoming results. The consensus analyst estimate has gone from a ....more | Save |  Share  Email 24th Oct 2014 
    Neurologic Complications in Children of Diabetic Moms - Medscape
      COLUMBUS, Ohio - Babies born to mothers with type 1 diabetes may have alarming rates of hypotonia (low muscle tone) and congenital malformations, including various types of neural tube defects, a new pilot study suggests. However, good co ....more | Save |  Share  Email 24th Oct 2014 
    East Coast Biotech Roundup: PureTech, Celgene, Unum, Biogen & More - Xconomy
      Deal flow is in full swing on the East Coast. At least three life sciences startups launched out of Boston and New York this week, with a few other firms filling up their bank accounts with either new funding rounds or par ....more | Save |  Share  Email 24th Oct 2014 
    Vaxart accelerates Ebola tablet vaccine development - Pharmaceutical Business Review
      Browse By Network. Business Review Sites. Production & Manufacturing Drug Research Contract Research & Services Automation Fine & Speciality Chemicals Manufacturing Process & Production OTC Dru ....more | Save |  Share  Email 24th Oct 2014 
    Biotech Breakout: Technical Analysis And Major News - Seeking Alpha (registration)
      Biotech stocks experienced major breakouts and lead the market charge today with the IBB up 2.7% and the XBI up 3.8%. Positive Celgene GED-0301 data and activist activity in Amgen have contributed to a 14% plus move in t ....more | Save |  Share  Email 24th Oct 2014 
    3 Money-Making Biotech Stocks That Could Go Higher - Motley Fool
      Motley Fool Biotechnology investors often have to make bets based more on promise than profit. That's because it takes years and hundreds of millions of dollars to advance new medicine through clinical trials to market, so investing in ....more | Save |  Share  Email 24th Oct 2014 
    Biotech Stock Mailbag: Rockwell Medical, Oxigene, Prosensa, Sarepta - TheStreet.com
      Stuart A. writes: "Adam, Rockwell Medical has an FDA advisory committee meeting coming up soon. Can you talk about the issues that might be raised there?" The Food and Drug Administration is conveni ....more | Save |  Share  Email 24th Oct 2014 
    Merrimack Pharmaceuticals (MACK) Looks Strong: Stock Up 8.6% - Zacks.com
      Merrimack Pharmaceuticals, Inc. (MACK - Snapshot Report) was a big mover last session, as the company saw its shares jump nearly 9% on the day. This rise can be attributable to solid volume with far more shares changing hands than ....more | Save |  Share  Email 24th Oct 2014 
    Elite Pharmaceuticals Announces New Management Appointments - Nasdaq
      NORTHVALE, N.J., Oct. 24, 2014 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP),a specialty pharmaceutical company developing a pipeline of abuse-deterrent opioids and niche g ....more | Save |  Share  Email 24th Oct 2014 
    Hikma Pharmaceuticals Plc Given Hold Rating at Panmure Gordon (HIK) - WKRB News
      Hikma Pharmaceuticals Plc logo Panmure Gordon reissued their hold rating on shares of Hikma Pharmaceuticals Plc (LON:HIK) in a research report sent to investors on Friday morning. The firm currently has a GBX 1,580 ($25.43) ....more | Save |  Share  Email 24th Oct 2014 
    Roche to invest $3.2bn in Basel site development - Pharmaceutical Business Review
      Roche CEO Severin Schwan said the company is committed long-term to Switzerland and to Basel in its dual role as corporate headquarters and one of its most important sites worldwide. "The entire value chai ....more | Save |  Share  Email 24th Oct 2014 
    Sunlight is key to diabetes fight: Scientists find the sun can actually STOP ... - Express.co.uk
      Express.co.uk The discovery couldlead to a treatment that halts the progress of Type 2 diabetes, which is fuelled by obesity and an unhealthy lifestyle and costs the NHS 9billion a year. Scientists from Ed ....more | Save |  Share  Email 24th Oct 2014 
    Dechra Pharmaceuticals share price: Company Halts Development Of Feline ... - iNVEZZ
      The Business Desk (registration) Dechra Pharmaceuticals PLC (LON:DPH) Friday reiterated confidence that the "execution ofstrategy will continue to deliver growth", as it traded in line with expectations in i ....more | Save |  Share  Email 24th Oct 2014 
    BRIEF-Dechra Pharmaceuticals Q1 reported revenue up 6 pct - Reuters
      Oct 24 (Reuters) - Dechra Pharmaceuticals Plc. * Group revenue for Q1 increased by approximately 12 pct at constant currency (6 pct reported). * Group trading in Q1 has been in line with management expectation. * Group trading in Q1 ha ....more | Save |  Share  Email 23rd Oct 2014 
    Pacific Biosciences of California's (PACB) CEO Michael Hunkapiller on Q3 2014 ... - Seeking Alpha (registration)
      Dr. Stuart Scott from the Icahn School of Medicine at Mount Sinai described using SMRT sequencing of multiplexed amplicons to study epigenetics and pharmacogenetics in human samples. Dr. ....more | Save |  Share  Email 23rd Oct 2014 
    Coshocton Hospital class combats diabetes - Coshocton Tribune
      Coshocton Tribune Cathy Hawk, of Coshocton, examines the nutritional facts on a jar of peanut butter Oct. 23 at Baker's IGA in the Downtowner Plaza during "Take Charge of Diabetes,? a free six-week program hosted by Coshocton Hospital. ....more | Save |  Share  Email 23rd Oct 2014 
    'Sunshine can slow weight gain and diabetes symptoms' - BBC News
      BBC News Exposure to sunshine could slow down weight gain and the development of type 2 diabetes, research on mice suggests. Writing in Diabetes, scientists from Edinburgh, Southampton and Australia found that shining UV light on o ....more | Save |  Share  Email 23rd Oct 2014 
    Total record(s) 1136 , Page No. 1 , Max 20 Records Per Page -
    Page Nos. 1 2 3 4 5 6 7 8 9 10 .... Next >>